These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22781678)

  • 1. The Multiple Myeloma Research Foundation's evolving focus on drug R&D.
    Giusti K
    Nat Biotechnol; 2012 Jul; 30(7):600-3. PubMed ID: 22781678
    [No Abstract]   [Full Text] [Related]  

  • 2. One foundation's strategy to accelerate drug discovery through genomics.
    Perkins LM; Young AQ; Giusti K
    Sci Transl Med; 2011 Apr; 3(78):78cm11. PubMed ID: 21490273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonprofit foundations for open-source biomedical technology development.
    Frangioni JV
    Nat Biotechnol; 2012 Oct; 30(10):928-32. PubMed ID: 23051807
    [No Abstract]   [Full Text] [Related]  

  • 4. Foundation drives research agenda for multiple myeloma.
    Hede K
    J Natl Cancer Inst; 2006 May; 98(9):573. PubMed ID: 16670379
    [No Abstract]   [Full Text] [Related]  

  • 5. Allina Foundation's Project DECIDE (Discussion of Evolving Choices in Dying and Ethics).
    Jossi F
    Healthplan; 1997; 38(3):25-6, 30-1. PubMed ID: 10176861
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonprofit foundations spur translational research.
    Zaratin P; Battaglia MA; Abbracchio MP
    Trends Pharmacol Sci; 2014 Nov; 35(11):552-5. PubMed ID: 25441773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation's Perspective.
    Yerxa B
    Pharm Res; 2018 Oct; 35(11):239. PubMed ID: 30338398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.
    Bertolotti P; Bilotti E; Colson K; Curran K; Doss D; Faiman B; Gavino M; Jenkins B; Lilleby K; Love G; Mangan PA; McCullagh E; Miceli T; Miller K; Rogers K; Rome S; Sandifer S; Smith LC; Tariman JD; Westphal J
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):9-12. PubMed ID: 18490252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quest for better contraception: the Ford Foundation's contribution to reproductive science and contraceptive development 1959-1983.
    Hertz R
    Contraception; 1984 Feb; 29(2):107-42. PubMed ID: 6723310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in clinical research: the Women's Cancer Research Foundation's experience.
    Micha JP; Graham CL; Rettenmaier MA; Brown JV; Goldstein BH
    Perspect Health Inf Manag; 2009; 6():1. PubMed ID: 19169377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A success for science or technology? The Rockfeller Foundation's role in malaria eradication in Italy, 1924-1935.
    Stapleton DH
    Med Secoli; 1994; 6(1):213-28. PubMed ID: 11640168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-associated side effects in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
    Faiman B; Bilotti E; Mangan PA; Rogers K;
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):53-63. PubMed ID: 18490257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelosuppression associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
    Miceli T; Colson K; Gavino M; Lilleby K;
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):13-20. PubMed ID: 18490253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field building: lessons from the Robert Wood Johnson Foundation's anthology series.
    Isaacs SL; Knickman JR
    Health Aff (Millwood); 2005; 24(4):1161-5. PubMed ID: 16012156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V Foundation's efforts to support cancer research.
    Simmons M
    N C Med J; 2014; 75(4):295-6. PubMed ID: 25046100
    [No Abstract]   [Full Text] [Related]  

  • 16. Secret of Hellenic Foundation's success? Its staff.
    Nasikas NK
    Nature; 2021 Dec; 600(7890):606. PubMed ID: 34934199
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrointestinal side effects associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
    Smith LC; Bertolotti P; Curran K; Jenkins B;
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):37-52. PubMed ID: 18490256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The American Nurses' Foundation's contributions to research in nursing.
    Hyde A
    Nurs Res; 1977; 26(3):225-7. PubMed ID: 585842
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboembolic events associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
    Rome S; Doss D; Miller K; Westphal J;
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):21-8. PubMed ID: 18490254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rockefeller Foundation's antimalarial program in Latin America: donating or dominating?
    Franco-Agudelo S
    Int J Health Serv; 1983; 13(1):51-67. PubMed ID: 6832874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.